540694 — ANG Lifesciences India Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for ANG Lifesciences India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	36	38.6	183	185	173
Net Total Accounts Receivable
Net Total Receivables	533	820	1,021	1,123	733
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	727	1,159	1,928	1,869	1,789
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	209	239	926	881	584
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	941	1,437	2,910	2,797	2,424
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	509	916	1,663	1,623	1,446
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	595	1,021	2,073	1,935	1,662
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	346	416	838	862	763
Total Liabilities & Shareholders' Equity	941	1,437	2,910	2,797	2,424
Total Common Shares Outstanding